Expanding Access to Biospecimens for Lyme Disease Test Development.

Area of Science:

• Medical Diagnostics
• Infectious Diseases
• Microbiology

Background:

• Lyme disease diagnosis relies on serologic testing, often using a two-tiered algorithm.
• Current methods lack sensitivity in early Lyme disease stages.
• Developing advanced diagnostics necessitates high-quality biospecimens with reliable clinical data.

Purpose of the Study:

• To describe the development of the Lyme Disease Biobank.
• To provide a resource of well-characterized biospecimens for Lyme disease diagnostic research.
• To support the development of novel diagnostic approaches, including those using alternative specimen types.

Main Methods:

• Established a biobank with clinically categorized early Lyme disease patients and healthy controls from endemic areas.
• Collected whole blood and urine samples, processed and stored at a central biorepository.
• Performed extensive laboratory testing, including serologic and nucleic acid amplification tests, on collected samples.

Main Results:

• Direct detection methods yielded limited positive results.
• The biobank showed a low seropositive rate compared to other cohorts using standard two-tiered testing.
• Few subjects exhibited seroconversion in convalescent-phase samples.

Conclusions:

• The Lyme Disease Biobank is a valuable resource for developing novel Lyme disease diagnostics.
• The characterized samples, including whole blood and urine, aid in advancing antibody detection technologies.
• This resource supports research into more sensitive and accurate diagnostic methods for Lyme disease.